residues of D-alloThx and a (3i?)-hydroxypalmitic acid. Its structure, including absolute configurations, was unequivocally determined as 1 based on chemical and spectroscopic evidence.
Until advent of FR901469, l,3-/3-glucan synthase inhibitors could be classified into two groups, the echinocandin family and the papulacandins. Spectroscopic and amino acid analysis have shown that FR901469 is a new cyclic lipopeptide, consisting of twelve amino acids and 3-hydroxypalmitic acid. The structure of FR901469 (1) ( Fig. 1 ) is markedly different from those of echinocandinlike lipopeptides and therefore FR901469 adds a new structural variation to l,3-/5-glucan synthase inhibitors. Its discovery, isolation, characterization and biological properties are described in the previous publication.1>2 ) In this paper we report structure elucidation of FR901469 on the basis of chemical and spectroscopic evidence.
Planar Structure Elucidation
The substance of FR901469 (1) NMRdata (see Table 1 ). In the IR spectrum, a strong amide absorption at 1660 cm"1 with a weak shoulder at 1730 cm"1 suggested a peptide containing an ester function. Alkaline hydrolysis of 1 (1 N NaOH, room temperature) gave a linear peptide (2) whose molecular weight was 18 more than 1, providing the first evidence that 1 contains a lactone. Amino acid analysis of the acid hydrolysate of 1 (6N HC1, 1 10°C, 18 hours) revealed the presence of one residue each ofAla, Tyr, Val, Gly, Orn, NH3 and four residues ofThr and three unknownamino acids.
The !H NMRspectra measured in DMSO-d6and D2O displayed broadened signals, which were not suitable for a detailed analysis. Sharp and well-resolved signals in the !H NMRspectra were obtained in CD3OD.Since an amide NH proton was essential in assigning the sequence of the peptide, CD3OHwas employed instead of CD3OD.A detailed analysis of COSY, HOHAHA, HSQCand HMBC spectra revealed 13 subunits (a~m) as shown in Fig. 2 .
The structural assignments of the nine commonamino acid residues (a, b, c, d, f, g, j, k and 1) were easily made.
The structure elucidation of the three unusual ones (e, h and i) was as follows. 4-Hydroxyproline (4-OHPro) (e):
The HMBCcorrelations between 5-H2 and C-2 indicated the presence of a pyrrolidine ring and HMBC correlations The molecular formula and the 13C NMRdata (see Table 1 ) indicated the presence of 22 exchangeable protons which was satisfied by the subunits. Twenty-one degrees of unsaturation required by the molecular formula could be accounted for with the fragments a~mand one lactone ring.
The peptide sequence and position of attachment of 3-OHPal chain was unambiguously established by a combination of !H-13C long-range HMBCand NOESY spectra as depicted in Fig. 3 . The HMBC sequence analysis revealed -Thr'-Ala^Tyr^-Val4-and -4OHPro5-Thr6-Thr7-3OHPro8-3OHGln9-Gly^-Thr1^Orn12-. There were no
HMBCcross-peaks between Val4 and 4OHPro5. Linkage of Val4 to 4OHPro5 was obtained by NOESYcross-peaks between 2-H in Val4 and 5-H2 in 4OHPro5. With the exception of the connection of 4OHPro5 and Thr6, the peptide sequence was further supported by the NOESY data (Fig. 3) . Linking 3OHPal to Thr1 via an amide bond was evident from the HMBC correlation from NHin Thr1 to C-l in 30HPal and an NOEbetween NHin Thr1 and 2-confirmed by FAB MS/MSfragmentation analysis of a H9 in 3OHPal. HMBCcorrelation between the 3-H in linear peptide (2) to be shown in Fig. 4 . The complete !H 3OHPaland the carbonyl ofOrn formed the 40-membered and 13C NMRsignal assignments were listed in Table 1 .
macrocyclic lactone. The entire peptide sequence was The only remaining structural problems, namely the positions of L-Thr and three residues of D-a//oThr, were solved by chemical methods coupled with enzyme digestion in the following manner (Fig. 5) programmed from 80°to 210°at 3°C/minute and ZAB-SE mass spectrometer operating in the positive El mode(scan range between mlz 30 and 600 with repetition time of 1.5 seconds). Derivatization of amino acid residues was done as follows. Acid hydrolysate of 1 was heated in 10% HC1 in nBuOH(0.25 ml) 'at 100°C for 20 minutes in a screw-capped test tube. After removal of the #-butanolic HC1in vacuo, CH2C12 (0.3 ml) and trifluoroacetic anhydride (0.2 ml) were added, and the mixture was kept at 100°C for 5 minutes.
The mixture was evaporated, dissolved in EtOAc, and subjected to the analysis. Retention time (minute): D-Ala Linear Peptide (2) Compound 1 (500mg) was dissolved in aq In NaOH solution (1.0ml) and the reaction mixture was stirred at roomtemperature for 2 hour. The mixture was neutralized with 1n HC1and then applied to a column of HP-20SS (50ml). After washed with H2O(150ml), the column was eluted with MeOH. The product fractions were collected and evaporated to dryness under reduced pressure. The residue was triturated with diethyl ether to give linear peptide 2 as a colorless powder (470mg To a solution of 2 (50mg) in 0.3m Na2PO4 buffer (pH 5.8) (50ml) was added Actinoplanes utahensis (5 g wet) and the solution was incubated for 5 days at 37°C. After filtration, the filtrate was charged on a columnof HP20SS (30ml) washed with water, then eluted with MeOH.The product was purified by RP-HPLC. RP-HPLC was performed with a C18 HPLC column and eluted with CH3CN-0.1% aqueous TFA using a linear gradient from 10 to 90% over 30 minutes to give deacylated dodecapeptide (3) as a white powder (30mg). Edman Degradation of 3 To a solution of3 (30mg) in 50% aq pyridine (1 ml) was added PITC (50jUl) and the mixture was heated for 20 minutes at 55°C. After rinsing the solution with benzene (lml, three times), the aq layer was dried under a N2
stream. The residue was dissolved in TFA (200 fA) and the solution was heated for 5 minutes at 55°C. After removal of the TFAunder a N2 stream, the residue was dissolved in
